2022. Therapeutic drug monitoring of gabapentin: the applicability in patients with neuropathic pain. Brazilian Journal of Pharmaceutical Sciences. 58, (Nov. 2022). DOI:https://doi.org/10.1590/s2175-97902022e191073.